1. Academic Validation
  2. Downregulation of connexin 43 potentiates amitriptyline-induced brain-derived neurotrophic factor expression in primary astrocytes through lysophosphatidic acid receptor1/3, Src, and extracellular signal-regulated kinase

Downregulation of connexin 43 potentiates amitriptyline-induced brain-derived neurotrophic factor expression in primary astrocytes through lysophosphatidic acid receptor1/3, Src, and extracellular signal-regulated kinase

  • Eur J Pharmacol. 2022 Jun 15;925:174986. doi: 10.1016/j.ejphar.2022.174986.
Nozomi Tokunaga 1 Tomoyo Takimoto 1 Yoki Nakamura 1 Kazue Hisaoka-Nakashima 1 Norimitsu Morioka 2
Affiliations

Affiliations

  • 1 Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima, 734-8553, Japan.
  • 2 Department of Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi Minami-ku, Hiroshima, 734-8553, Japan. Electronic address: [email protected].
Abstract

Connexin 43 (Cx43) expression is decreased in the prefrontal cortex of patients with depression, but its significance is still unknown. Neurotrophic Factors, such as brain-derived neurotrophic factor (BDNF), are involved in the effects of antidepressant. However, the relationship between Cx43 expression and induction of brain-derived neurotrophic factor production by antidepressants is unknown. On the basis of our previous study, which showed that adrenergic receptors stimulation results in potentiation of BDNF expression in astrocytes with downregulated Cx43 expression, we investigated the induction of BDNF expression by amitriptyline, a tricyclic antidepressant, in Cx43-knockdown astrocytes. Amitriptyline treatment potentiated BDNF expression in Cx43-knockdown astrocytes compared with those treated with non-targeting small interfering RNA (siRNA). Using a pharmacological approach, we revealed that the potentiating effect of amitriptyline on BDNF expression was mediated by lysophosphatidic acid (LPA) receptor1/3 (LPA1/3) stimulation and subsequent activation of Src-extracellular signal-regulated kinase (ERK) signaling. These findings suggest that downregulation of Cx43 in patients with depression might contribute to the therapeutic efficacy of antidepressants rather than the pathogenesis of depression.

Keywords

Astrocytes; Brain-derived neurotrophic factor; Connexin 43; Extracellular signal-regulated kinase; Lysophosphatidic acid receptor; Src.

Figures
Products